Literature DB >> 24283256

Critical research concepts in tuberculosis vaccine development.

G Delogu1, R Manganelli, M J Brennan.   

Abstract

A new and improved vaccine against tuberculosis (TB) would provide a powerful tool to conquer one of the most insidious infectious diseases of mankind. Protection afforded by bacillus Calmette-Guérin (BCG) has been shown to be limited and inconsistent, especially in adults that are known to transmit TB disease. In the last two decades, several new vaccines have been developed and tested with the aim to elicit robust and long-lived T-cell responses against Mycobacterium tuberculosis antigens. Although much progress has been made in the TB vaccine field, there is an urgent need to address critical research questions about TB immunity with a special focus on designing vaccines aimed at preventing infection and transmission of TB. Here, we discuss the rationale behind the current immunization strategies being implemented for TB vaccines and provide some suggestions for hypothesis driven research to encourage the development of novel TB vaccines.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Bacillus Calmette-Guérin; Mycobacterium tuberculosis; disease transmission; tuberculosis; vaccines

Mesh:

Substances:

Year:  2014        PMID: 24283256     DOI: 10.1111/1469-0691.12460

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  12 in total

1.  CHO expressed recombinant human lactoferrin as an adjuvant for BCG.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int J Immunopathol Pharmacol       Date:  2015-08-27       Impact factor: 3.219

2.  Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.

Authors:  Kaustuv Nayak; Lichen Jing; Ronnie M Russell; D Huw Davies; Gary Hermanson; Douglas M Molina; Xiaowu Liang; David R Sherman; William W Kwok; Junbao Yang; John Kenneth; Syed F Ahamed; Anmol Chandele; Kaja Murali-Krishna; David M Koelle
Journal:  Tuberculosis (Edinb)       Date:  2015-03-27       Impact factor: 3.131

3.  Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate.

Authors:  Rogelio Hernandez-Pando; Sung Jae Shin; Simon Clark; Stefano Casonato; Martin Becerril-Zambrano; Hongmin Kim; Francesca Boldrin; Dulce Mata-Espinoza; Roberta Provvedi; Ainhoa Arbues; Brenda Marquina-Castillo; Laura Cioetto Mazzabò; Jorge Barrios-Payan; Carlos Martin; Sang-Nae Cho; Ann Williams; Riccardo Manganelli
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

4.  Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection.

Authors:  Wasiulla Rafi; Kamlesh Bhatt; William C Gause; Padmini Salgame
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

5.  An Update on Tuberculosis Vaccines.

Authors:  Radha Gopalaswamy; Selvakumar Subbian
Journal:  Methods Mol Biol       Date:  2022

6.  Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.

Authors:  Ying Xu; Enzhuo Yang; Jianguang Wang; Rui Li; Guanghua Li; Guoyuan Liu; Na Song; Qi Huang; Cong Kong; Honghai Wang
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

7.  Mycobacterium tuberculosis requires the ECF sigma factor SigE to arrest phagosome maturation.

Authors:  Stefano Casonato; Roberta Provvedi; Elisa Dainese; Giorgio Palù; Riccardo Manganelli
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Impact of protein domains on PE_PGRS30 polar localization in Mycobacteria.

Authors:  Flavio De Maio; Giuseppe Maulucci; Mariachiara Minerva; Saber Anoosheh; Ivana Palucci; Raffaella Iantomasi; Valentina Palmieri; Serena Camassa; Michela Sali; Maurizio Sanguinetti; Wilbert Bitter; Riccardo Manganelli; Marco De Spirito; Giovanni Delogu
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

9.  Multiple consecutive infections might explain the lack of protection by BCG.

Authors:  Pere-Joan Cardona; Cristina Vilaplana
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

10.  PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2.

Authors:  Ivana Palucci; Serena Camassa; Alessandro Cascioferro; Michela Sali; Saber Anoosheh; Antonella Zumbo; Mariachiara Minerva; Raffaella Iantomasi; Flavio De Maio; Gabriele Di Sante; Francesco Ria; Maurizio Sanguinetti; Giorgio Palù; Michael J Brennan; Riccardo Manganelli; Giovanni Delogu
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.